Affordable Access

deepdyve-link
Publisher Website

Recent patenting activities in the discovery and development of vasopressin V2 receptor agonists.

Authors
  • Tsukamoto, Issei
Type
Published Article
Journal
Expert Opinion on Therapeutic Patents
Publisher
Informa UK (Taylor & Francis)
Publication Date
Jun 01, 2012
Volume
22
Issue
6
Pages
579–586
Identifiers
DOI: 10.1517/13543776.2012.692778
PMID: 22630566
Source
Medline
License
Unknown

Abstract

The V(2) receptor is currently one of the hottest therapeutic targets investigated for the treatment of urinary disorders such as nocturia and central diabetes. Over the past 10 years, significant progress has been made in the discovery and development of vasopressin V(2) receptor agonists, for the treatment of these disorders. The author anticipates that these agonists will be launched to market in the not-too-distant future.

Report this publication

Statistics

Seen <100 times